Advertisement

Acute Inflammatory Bowel Disease

  • Goran Augustin
Chapter

Abstract

The incidence of inflammatory bowel disease is rising in general population, especially in adolescence and early adulthood, and consequently, it is rising in pregnant population. Interestingly the severity and progression of the disease depend on the disease activity during pregnancy. Therefore, it is mandatory to have a patient in a remission before planned pregnancy for minimization of the possibility of the disease progression and complications during pregnancy. When inflammatory bowel disease during pregnancy is active, an additional problem is the use of immunomodulatory and biologic agents which can influence fetal development. On the other hand, prolonged infection during pregnancy increases the rate of preterm labor, fetus small for gestational age, and other obstetric complications. An additional problem is pouch surgery before and during pregnancy because functional results can be lower due to the compression of growing uterus. Also, type of delivery could be influenced by the pouch surgery and pouch function at the time of delivery.

References

  1. 1.
    Fabry W, editor. Observations chirurgiques. Traduites par un de Medicin. Geneve; 1669.Google Scholar
  2. 2.
    Crohn BB, Ginzburg L, Oppenheimer G. Regional ileitis. A pathological and clinical entity. JAMA. 1932;99:1323–9.CrossRefGoogle Scholar
  3. 3.
    Thomas GA, Millar-Jones D, Rhodes J, et al. Incidence of Crohn’s disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol. 1995;7:401–5.PubMedGoogle Scholar
  4. 4.
    Logan R. Inflammatory bowel disease incidence: up, down or unchanged? Gut. 1998;42:309–11.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Armitage E, Drummond H, Ghosh S, et al. Incidence of juvenile-onset Crohn’s disease in Scotland. Lancet. 1999;353:1496–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Gunesh S, Thomas GA, Williams G, et al. The incidence of Crohn’s disease in Cardiff over the last 75 years: an update for 1996-2005. Aliment Pharmacol Ther. 2008;27:211–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Munkholm P. Crohn’s disease—occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull. 1997;44:287–302.PubMedGoogle Scholar
  8. 8.
    Baiocco PJ, Korelitz B. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol. 1984;6:211–6.PubMedGoogle Scholar
  9. 9.
    Heetun ZS, Byrnes C, Neary P, et al. Review article: reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther. 2007;26:513–33.CrossRefPubMedGoogle Scholar
  10. 10.
    Babson W. Terminal ileitis with obstruction and abscess complicating pregnancy. N Engl J Med. 1946;235:544–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Nelson JL, Hughes KA, Smith A, et al. Maternal-fetal disparity in HLA class II alloantigens and pregnancy-induced amelioratiion of rheumatoid arthritis. N Engl J Med. 1993;329:466–71.CrossRefPubMedGoogle Scholar
  12. 12.
    Kane S, Kisiel J, Shih L, et al. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am J Gastroenterol. 2004;99:1523–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Fevoid HL, Hisaw FL, Meyer R. The relaxative hormone of corpus luteum. Its purification and concentration. J Am Chem Soc. 1930;52:3340–8.CrossRefGoogle Scholar
  14. 14.
    Munkholm P. Pregnancy, fertility, and disease course in patients with Crohn’s disease and ulcerative colitis. Eur J Intern Med. 2000;11:215–21.CrossRefPubMedGoogle Scholar
  15. 15.
    Nwokolo CU, Tan WC, Andrews HA, et al. Surgical resections in parous patients with distal ileal and colonic Crohn’s disease. Gut. 1994;35:220–3.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Peters RW, Fry RD, Fleshman JW, et al. Multiple blood transfusions reduce the recurrence rate of Crohn’s disease. Dis Colon Rectum. 1992;32:749–53.CrossRefGoogle Scholar
  17. 17.
    Crohn BB, Yarnis H, Regional KB. ileitis complicating pregnancy. Gastroenterology. 1956;31:615–28.PubMedGoogle Scholar
  18. 18.
    Norton RA, Patterson J. Pregnancy and regional ileitis. Obstet Gynecol. 1972;40:711–2.PubMedGoogle Scholar
  19. 19.
    Khosla R, Willoughby CP, Jewell DP. Crohn’s disease and pregnancy. Gut. 1984;25:52–6.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Abramson D, Jankelson IR, Milner L. Pregnancy in idiopathic ulcerative colitis. Am J Obstet Gynecol. 1951;61:121–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Thomas GA, Rhodes J, Green JT, et al. Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J. 2000;76:273–9.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Sorokin J. Pregnancy and inflammatory bowel disease. Obstet Gynecol. 1983;62:247–51.PubMedGoogle Scholar
  23. 23.
    Agret F, Cosnes J, Hassani Z, et al. Impact of pregnancy on the clinical activity of Crohn’s disease. Aliment Pharmacol Ther. 2005;21:509–13.CrossRefPubMedGoogle Scholar
  24. 24.
    Triantafillidis JK, Malgarinos G, Gikas A, et al. Pregnancy and inflammatory bowel disease in Greece: a prospective study of seven cases in a single hospital setting. Ann Gastroenterol. 2007;20:29–34.Google Scholar
  25. 25.
    Smink M, Lotgering FK, Albers L, et al. Effect of childbirth on the course of Crohn’s disease; results from a retrospective cohort study in the Netherlands. BMC Gastroenterol. 2011;11:6.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Summers RW, Switz DM, Sessions JT, et al. National Cooperative Crohn’s Disease Study: results of drug treatment. Gastroenterology. 1979;77:847–69.PubMedGoogle Scholar
  27. 27.
    Rogers RG, Katz VL. Course of Crohn’s disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol. 1995;12:262–4.CrossRefPubMedGoogle Scholar
  28. 28.
    Hanan I. Inflammatory bowel disease in the pregnant woman. Compr Ther. 1993;19:91–5.PubMedGoogle Scholar
  29. 29.
    Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch Gynecol Obstet. 2004;270:79–85.CrossRefPubMedGoogle Scholar
  30. 30.
    Pedersen N, Bortoli A, Duricova D, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013;38:501–12.CrossRefPubMedGoogle Scholar
  31. 31.
    Alstead EM, Nelson-Piercy C. Inflammatory bowel disease in pregnancy. Gut. 2003;52:159–61.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Nielsen OH, Andreasson B, Bondesen S, et al. Pregnancy in Crohn’s disease. Scand J Gastroenterol. 1984;19:724–32.CrossRefPubMedGoogle Scholar
  33. 33.
    Morales M, Berney T, Jenny A, et al. Crohn’s disease as a risk factor for the outcome of pregnancy. Hepato Gastroenterol. 2000;47:1595–8.Google Scholar
  34. 34.
    Moffatt DC, Ilnyckyj A, Bernstein C. A population-based study of breastfeeding in inflammatory bowel disease: initiation, duration, and effect on disease in the postpartum period. Am J Gastroenterol. 2009;104:2517–23.CrossRefPubMedGoogle Scholar
  35. 35.
    Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2005;100:102–5.CrossRefPubMedGoogle Scholar
  36. 36.
    Fonager K, Sørensen HT, Olsen J, et al. Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries. Am J Gastroenterol. 1998;93:2426–30.CrossRefPubMedGoogle Scholar
  37. 37.
    Hanan IM, Kirsner JB. Inflammatory bowel disease in the pregnant woman. Clin Perinatol. 1985;12:669–82.CrossRefPubMedGoogle Scholar
  38. 38.
    Mogadam M, Korelitz BI, Ahmed SW, et al. The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol. 1981;75:265–9.PubMedGoogle Scholar
  39. 39.
    Alstead EM. Inflammatory bowel disease in pregnancy. Postgrad Med J. 2002;78:23–6.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Subhani JM, Hamiliton MI. Review article: the management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther. 1998;12:1039–53.CrossRefPubMedGoogle Scholar
  41. 41.
    Castiglione F, Pignata S, Morace F, et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol. 1996;28:199–204.PubMedGoogle Scholar
  42. 42.
    Riis L, Vind I, Politi P, et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2006;101:1539–45.CrossRefPubMedGoogle Scholar
  43. 43.
    Korelitz BI. Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am. 1992;21:827–34.PubMedGoogle Scholar
  44. 44.
    Blair JSG, Allen N. Crohn’s disease presenting acutely during pregnancy. J Obstet Gynaecol Br Commonw. 1962;69:648–51.CrossRefGoogle Scholar
  45. 45.
    Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–53.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Solomon MJ, Deva AK, Corcoran SJ, Gallagher N. Postpartum avulsion of the terminal ileal wall in Crohn’s disease. Aust N Z J Surg. 1996;66:849–51.CrossRefPubMedGoogle Scholar
  48. 48.
    Amos JD, Schorr SJ, Norman P, et al. Laparoscopic surgery during pregnancy. Am J Surg. 1996;171:435–7.CrossRefPubMedGoogle Scholar
  49. 49.
    Cicarelli LM, Perroni AG, Zugaib M, et al. Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-α, interleukin-1β, and interleukin-8 during and after delivery. Mediators Inflamm. 2005;2005:96–100.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    de Villiers WJ, Louw JP, Strachan A, et al. C-reactive protein and serum amyloid A protein in pregnancy and labour. BJOG. 1990;97:725–30.CrossRefGoogle Scholar
  51. 51.
    Nesin M, Cunningham-Rundles S. Cytokines and neonates. Am J Perinatol. 2000;17:393–404.CrossRefPubMedGoogle Scholar
  52. 52.
    Nguyen GC, Kaplan GG, Harris M, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443–50.CrossRefGoogle Scholar
  53. 53.
    Issa M, Ananthakrishnan AN, Binion D. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1432–42.CrossRefPubMedGoogle Scholar
  54. 54.
    Shoenut JP, Semelka RC, Silverman R, et al. MRI in the diagnosis of Crohn’s disease in two pregnant women. J Clin Gastroenterol. 1993;17:244–7.CrossRefPubMedGoogle Scholar
  55. 55.
    Stern MD, Kopylov U, Ben-Horin S, et al. Magnetic resonance enterography in pregnant women with Crohn’s disease: case series and literature review. BMC Gastroenterol. 2014;14:1–9.CrossRefGoogle Scholar
  56. 56.
    Cappell MS, Sidhom O. Multicenter, multiyear study of safety and efficacy of flexible sigmoidoscopy during pregnancy in 24 females with follow-up of fetal outcome. Dig Dis Sci. 1995;40:472–9.CrossRefPubMedGoogle Scholar
  57. 57.
    Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut. 2006;55:1198–206.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Stengel JZ, Arnold HL. Is infliximab safe to use while breastfeeding? World J Gastroenterol. 2008;14(19):3085–7.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Habal FM, Ravindran NC. Management of inflammatory bowel disease in the pregnant patient. World J Gastroenterol. 2008;14:1326–32.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Koss CA, Baras DC, Lane S, et al. Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrob Agents Chemother. 2012;56:4800–5.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. BJOG. 1998;105:322–7.CrossRefGoogle Scholar
  62. 62.
    Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006;131:283–311.CrossRefPubMedGoogle Scholar
  63. 63.
    Gisbert J. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. Inflamm Bowel Dis. 2010;16:881–95.CrossRefPubMedGoogle Scholar
  64. 64.
    Osadchy A, Koren G. Cyclosporine and lactation: when the mother is willing to breastfeed. Ther Drug Monit. 2011;33:147–8.PubMedGoogle Scholar
  65. 65.
    Zeldis J. Pregnancy and inflammatory bowel disease. West J Med. 1989;151:168–71.PubMedPubMedCentralGoogle Scholar
  66. 66.
    Khan AK, Truelove S. Placental and mammary transfer of sulphasalazine. BMJ. 1979;2:1553.CrossRefPubMedGoogle Scholar
  67. 67.
    Jarnerot G, Andersen S, Esbjorner E, et al. Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand J Gastroenterol. 1981;16:1049–55.CrossRefPubMedGoogle Scholar
  68. 68.
    Esbjorner E, Jarnerot G, Wranne L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand. 1987;76:137–42.CrossRefPubMedGoogle Scholar
  69. 69.
    Diav-Citrin O, Park YH, Veerasuntharam G, et al. The safety of mesalazine in human pregnancy: a prospective controlled cohort study. Gastroenterology. 1998;114:23–8.CrossRefPubMedGoogle Scholar
  70. 70.
    Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol. 2008;25:271–5.CrossRefPubMedGoogle Scholar
  71. 71.
    Marteau P, Tennenbaum R, Elefant E, et al. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther. 1998;12:1101–8.CrossRefPubMedGoogle Scholar
  72. 72.
    Bell CM, Habal F. Safety of topical 5-aminosalicylic acid in pregnancy. Am J Gastroenterol. 1997;92:2201–2.PubMedGoogle Scholar
  73. 73.
    Ito S, Blajchman A, Stephenson M, et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993;68:1393–9.CrossRefGoogle Scholar
  74. 74.
    Nelis G. Diarrhoea due to 5-aminosalicylic acid in breast milk. Lancet. 1989;1:383.CrossRefPubMedGoogle Scholar
  75. 75.
    Olsen SF, Østerdal ML, Salvig JD, et al. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. Eur J Clin Nutr. 2007;61:976–85.CrossRefPubMedGoogle Scholar
  76. 76.
    Järnerot G. Management of IBD in pregnancy. Res Clin Forum. 1993;15:137–43.Google Scholar
  77. 77.
    Fielding JF, Cooke W. Pregnancy and Crohn’s disease. BMJ. 1970;2:76–7.CrossRefPubMedGoogle Scholar
  78. 78.
    Nielsen OH, Andreasson B, Bondesen S, et al. Pregnancy in ulcerative colitis. Scand J Gastroenterol. 1983;18:735–42.CrossRefPubMedGoogle Scholar
  79. 79.
    McEwan H. Ulcerative colitis in pregnancy. Proc R Soc Med. 1972;65:279–81.PubMedPubMedCentralGoogle Scholar
  80. 80.
    Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385–92.CrossRefGoogle Scholar
  81. 81.
    Korelitz B. Pregnancy, fertility, and inflammatory bowel disease. Am J Gastroenterol. 1985;80:365–70.PubMedGoogle Scholar
  82. 82.
    Modigliani R. Drug therapy for ulcerative colitis during pregnancy. Eur J Gastroenterol Hepatol. 1997;9:854–7.CrossRefPubMedGoogle Scholar
  83. 83.
    Willoughby CP, Truelove S. Ulcerative colitis and pregnancy. Gut. 1980;21:469–74.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Homar V, Grosek S, Battelino T. High-dose methylprednisolone in a pregnant woman with Crohn’s disease and adrenal suppression in her newborn. Neonatology. 2008;94:306–9.CrossRefPubMedGoogle Scholar
  85. 85.
    Beaulieu DB, Ananthakrishnan AN, Issa M. Budesonide induction and maintenance therapy for Crohn’s disease during pregnancy. Inflamm Bowel Dis. 2009;15:25–8.CrossRefPubMedGoogle Scholar
  86. 86.
    Burakoff R, Opper F. Pregnancy and nursing. Gastroenterol Clin N Am. 1995;24:689–98.Google Scholar
  87. 87.
    Nørgård B, Pedersen L, Fonager K, et al. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther. 2003;17:827–34.CrossRefPubMedGoogle Scholar
  88. 88.
    Zlatanic J, Korelitz BI, Rajapakse R, et al. Complications of pregnancy and child development after cessation of treatment with 6-mercaptopurine for inflammatory bowel disease. J Clin Gastroenterol. 2003;36:303–9.CrossRefPubMedGoogle Scholar
  89. 89.
    Francella A, Dyan A, Bodian C, et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003;124:9–17.CrossRefPubMedGoogle Scholar
  90. 90.
    Coelho J, Beaugerie L, Colombel J, et al. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut. 2011;60:198–203.CrossRefPubMedGoogle Scholar
  91. 91.
    Alstead EM, Ritchie JK, Lennard-Jones J, et al. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology. 1990;99:443–6.CrossRefPubMedGoogle Scholar
  92. 92.
    O’Connell J. Additional discussion on the safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003;126:1493.CrossRefGoogle Scholar
  93. 93.
    Kucerova M, Kocandrle V, Matousek V, et al. Chromosomal aberrations and sister-chromatid exchanges (SCEs) in patients undergoing long-term Imuran therapy. Mutat Res. 1982;94:501–9.CrossRefPubMedGoogle Scholar
  94. 94.
    Rajapakse RO, Korelitz BI, Zlatanic J, et al. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol. 2000;95:684–8.CrossRefPubMedGoogle Scholar
  95. 95.
    Akbari M, Shah S, Velayos F, et al. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:15–22.CrossRefPubMedGoogle Scholar
  96. 96.
    Committee on Drugs AA of Pediatrics. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776–9.CrossRefGoogle Scholar
  97. 97.
    Angelberger S, Reinisch W, Messerschmidt A, et al. Longterm follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis. 2011;5:95–100.CrossRefPubMedGoogle Scholar
  98. 98.
    Christensen LA, Dahlerup JF, Nielsen M. Azathioprine treatment during lactation. Aliment Pharmacol Ther. 2008;28:1209–13.CrossRefPubMedGoogle Scholar
  99. 99.
    Shibolet O, Regushevskaya E, Brezis M, et al. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev. 2005;(1):CD004277.Google Scholar
  100. 100.
    Jayaprakash A, Gould S, Lim AG, et al. Use of cyclosporin in pregnancy. Gut. 2004;53:1386–7.CrossRefPubMedPubMedCentralGoogle Scholar
  101. 101.
    Bertschinger P, Himmelmann A, Risti B, et al. Cyclosporine treatment of severe ulcerative colitis during pregnancy. Am J Gastroenterol. 1995;90:330.PubMedGoogle Scholar
  102. 102.
    Branche J, Cortot A, Bourreille A, et al. Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy. Inflamm Bowel Dis. 2009;15:1044–8.CrossRefPubMedGoogle Scholar
  103. 103.
    Reindl W, Schmid RM, Huber W. Cyclosporin A treatment of steroid-refractory ulcerative colitis during pregnancy: report of two cases. Gut. 2007;56:1019.CrossRefPubMedPubMedCentralGoogle Scholar
  104. 104.
    Lahiff C, Moss A. Cyclosporine in the management of severe ulcerative colitis while breast-feeding. Inflamm Bowel Dis. 2011;17:E78.CrossRefPubMedGoogle Scholar
  105. 105.
    Angelberger S, Reinisch W, Dejaco C. Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancy. Gut. 2006;55:1364–5.PubMedPubMedCentralGoogle Scholar
  106. 106.
    Van Assche G, Vermeire S, Rutgeerts P. Treatment of severe steroid refractory ulcerative colitis. World J Gastroenterol. 2008;14:5508–11.CrossRefPubMedPubMedCentralGoogle Scholar
  107. 107.
    Moss AC, Peppercorn M. Steroid-refractory severe ulcerative colitis: what are the available treatment options? Drugs. 2008;68:1157–67.CrossRefPubMedGoogle Scholar
  108. 108.
    Moretti ME, Sgro M, Johnson D, et al. Cyclosporine excretion into breast milk. Transplantation. 2003;75:2144–6.CrossRefPubMedGoogle Scholar
  109. 109.
    Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003;21:3365–9.CrossRefPubMedGoogle Scholar
  110. 110.
    Kane SV, Acquah L. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol. 2009;104:228–33.CrossRefPubMedGoogle Scholar
  111. 111.
    Mahadevan U, Kane S, Sandborn WJ, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn’s disease. Alimentary Pharmacol Ther. 2005;21:733–8.CrossRefGoogle Scholar
  112. 112.
    Vasiliauskas EA, Church JA, Silverman N, et al. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255–8.CrossRefPubMedPubMedCentralGoogle Scholar
  113. 113.
    Zelinkova Z, de Haar C, de Ridder L, et al. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther. 2011;33:1053–8.CrossRefPubMedPubMedCentralGoogle Scholar
  114. 114.
    Kane S, Ford J, Cohen R, et al. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn’s disease before and after delivery. J Clin Gastroenterol. 2009;43:613–6.CrossRefPubMedGoogle Scholar
  115. 115.
    Friedman S, Regueiro MD. Pregnancy and nursing in inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:265–73.CrossRefPubMedGoogle Scholar
  116. 116.
    Mahadevan U, Cucchiara S, Hyams J, et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn’s and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol. 2011;106:214–24.CrossRefPubMedGoogle Scholar
  117. 117.
    Rahier JF, Moutschen M, Van Gompel A, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology. 2010;49:1815–27.CrossRefPubMedGoogle Scholar
  118. 118.
    Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the TREATTM registry. Am J Gastroentrol. 2012;107:1409–22.CrossRefPubMedPubMedCentralGoogle Scholar
  119. 119.
    Katz JA, Antoni C, Keenan GF, et al. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn’s disease and rheumatoid arthritis. Am J Gastroenterol. 2004;99:2385–92.CrossRefPubMedGoogle Scholar
  120. 120.
    Caprilli R, Gassull MA, Escher J, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut. 2006;55:i36–58.CrossRefPubMedPubMedCentralGoogle Scholar
  121. 121.
    Sánchez Munoz D, Hoyas Pablos E, Ramirez Martin Del Campo M, et al. Term pregnancy in a patient with Crohn’s disease under treatment with adalimumab. Gastroenterol Hepatol. 2005;28:435.CrossRefPubMedGoogle Scholar
  122. 122.
    Coburn LA, Wise PE, Schwartz D. The successful use of adalimumab to treat active Crohn’s disease of an ileoanal pouch during pregnancy. Dig Dis Sci. 2006;51:2045–7.CrossRefPubMedGoogle Scholar
  123. 123.
    Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut. 2005;54:890.CrossRefPubMedPubMedCentralGoogle Scholar
  124. 124.
    Sills ES, Perloe M, Tucker MJ, et al. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol. 2001;46:366–8.CrossRefPubMedGoogle Scholar
  125. 125.
    Ostensen M, Eigenmann G. Etanercept in breast milk. J Rheumatol. 2004;31:1017–8.PubMedGoogle Scholar
  126. 126.
    Peltier M, James D, Ford J, et al. Infliximab levels in breastmilk of a nursing Crohn’s patient. Am J Gastroenterol. 2001;96:S312.CrossRefGoogle Scholar
  127. 127.
    Srinivasan R, Akobeng A. Thalidomide and thalidomide analogues for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2009;(2):CD007350.Google Scholar
  128. 128.
    Akobeng AK, Stokkers P. Thalidomide and thalidomide analogues for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2009;(2):CD007351.Google Scholar
  129. 129.
    Rahimi R, Nikfar S, Rahimi F, et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn’s disease. Dig Dis Sci. 2008;53:2524–31.CrossRefPubMedGoogle Scholar
  130. 130.
    Rahimi R, Nikfar S, Rezaie A, et al. meta-analysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for prevention of disease relapse and maintenance of remission. Arch Med Sci. 2008;4:185–90.Google Scholar
  131. 131.
    Elias J, Bozzo P, Einarson A. Are probiotics safe for use during pregnancy and lactation? Can Fam Physician. 2011;57:299–301.PubMedPubMedCentralGoogle Scholar
  132. 132.
    Cox KL, Byrne WJ, Ament M. Home total parenteral nutrition during pregnancy: a case report. JPEN J Parenter Enteral Nutr. 1981;5:246–9.CrossRefPubMedGoogle Scholar
  133. 133.
    Tresadern JC, Falconer GF, Turnberg LA, et al. Successful completed pregnancy in a patient maintained on home parenteral nutrition. BMJ. 1983;286:602–3.CrossRefPubMedGoogle Scholar
  134. 134.
    Main AN, Shenkin A, Black WP, et al. Intravenous feeding to sustain pregnancy in patient with Crohn’s disease. BMJ. 1981;283:1221–2.CrossRefPubMedGoogle Scholar
  135. 135.
    Teahon K, Pearson M, Levi AJ, et al. Elemental diet in the management of Crohn’s disease during pregnancy. Gut. 1991;32:1079–81.CrossRefPubMedPubMedCentralGoogle Scholar
  136. 136.
    Jones V. Comparison of total parenteral nutrition and elemental diet in induction of remission of Crohn’s disease. Long-term maintenance of remission by personalized food exclusion diets. Dig Dis Sci. 1987;32:100S–7S.CrossRefPubMedGoogle Scholar
  137. 137.
    O’Morain C, Segal AW, Levi A. Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. BMJ. 1984;288:1859–62.CrossRefPubMedGoogle Scholar
  138. 138.
    Goettler CE, Stellato T. Initial presentation of Crohn’s disease in pregnancy. Dis Colon Rectum. 2003;46:406–10.CrossRefPubMedGoogle Scholar
  139. 139.
    Hill J, Clark A, Scott NA. Surgical treatment of acute manifestations of Crohn’s disease during pregnancy. J R Soc Med. 1997;90:64–6.CrossRefPubMedPubMedCentralGoogle Scholar
  140. 140.
    Dozois EJ, Wolff BG, Tremaine WJ, et al. Maternal and fetal outcome after colectomy for fulminant ulcerative colitis during pregnancy: case series and literature review. Dis Colon Rectum. 2006;49:64–73.CrossRefPubMedGoogle Scholar
  141. 141.
    Boreham PF, Soltau D. Pregnancy and Crohn’s disease. BMJ. 1970;2:541.CrossRefPubMedGoogle Scholar
  142. 142.
    Soltau D. Crohn’s disease and pregnancy. BMJ. 1972;3:760–1.CrossRefPubMedGoogle Scholar
  143. 143.
    Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease—a population-based cohort study. Am J Obstet Gynecol. 1997;177:942–6.CrossRefPubMedGoogle Scholar
  144. 144.
    Nguyen GC, Boudreau H, Harris ML, et al. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2009;7:329–34.CrossRefPubMedGoogle Scholar
  145. 145.
    Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56:830–7.CrossRefPubMedGoogle Scholar
  146. 146.
    Kwee A, Elferink-Stinkens PM, Reuwer PJ, et al. Trends in obstetric interventions in the Dutch obstetrical care system in the period 1993-2002. Eur J Obstet Gynecol Reprod Biol. 2007;132:70–5.CrossRefPubMedGoogle Scholar
  147. 147.
    Counihan TC, Roberts PL, Schoetz DJ, et al. Fertility and sexual and gynecologic function after ileal pouch-anal anastomosis. Dis Colon Rectum. 1994;37:1126–9.CrossRefPubMedGoogle Scholar
  148. 148.
    Nelson H, Dozois RR, Kelly K, et al. The effect of pregnancy and delivery on the ileal pouch–anal anastomosis functions. Dis Colon Rectum. 1989;32:384–8.CrossRefPubMedGoogle Scholar
  149. 149.
    Metcalf AM, Dozois RR, Beart RW Jr, et al. Pregnancy following ileal pouch-anal anastomosis. Dis Colon Rectum. 1985;28:859–61.CrossRefPubMedGoogle Scholar
  150. 150.
    Juhasz ES, Fozard B, Dozois R, et al. Ileal pouch-anal anastomosis function following childbirth. Dis Colon Rectum. 1995;38:159–65.CrossRefPubMedGoogle Scholar
  151. 151.
    Remzi FH, Gorgun E, Bast J, et al. Vaginal delivery after ileal pouch–anal anastomosis: a word of caution. Dis Colon Rectum. 2005;48:1691.CrossRefPubMedGoogle Scholar
  152. 152.
    Ananthakrishnan AN, Cheng A, Cagan A, et al. Mode of childbirth and long-term outcomes in women with inflammatory bowel diseases. Dig Dis Sci. 2015;60:471–7.CrossRefPubMedGoogle Scholar
  153. 153.
    Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis. 2010;4:63–101.CrossRefPubMedPubMedCentralGoogle Scholar
  154. 154.
    Ilnyckyji A, Blanchard JF, Rawsthorne P, et al. Perianal Crohn’s disease and pregnancy: role of the mode of delivery. Am J Gastroenterol. 1999;94:3274–8.CrossRefPubMedGoogle Scholar
  155. 155.
    Beniada A, Benoist G, Maurel J, et al. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod. 2005;34:581–8.CrossRefGoogle Scholar
  156. 156.
    Brandt LJ, Estabrook SG, Reinus J. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn’s disease. Am J Gastroenterol. 1995;90:1918–22.PubMedGoogle Scholar
  157. 157.
    Watson WJ, Gaines TE. Third-trimester colectomy for severe ulcerative colitis. A case report. J Reprod Med Obstet Gynecol. 1987;32:869–72.Google Scholar
  158. 158.
    Moser MA, Okun NB, Mayes DC, et al. Crohn’s disease, pregnancy, and birth weight. Am J Gastroenterol. 2000;95:1021–6.CrossRefPubMedGoogle Scholar
  159. 159.
    De Dombal FT, Burton IL, Goligher J. Crohn’s disease and pregnancy. BMJ. 1972;3:550–3.CrossRefPubMedGoogle Scholar
  160. 160.
    Porter RJ, Stirrat G. The effects of inflammatory bowel disease on pregnancy: a case-controlled retrospective analysis. BJOG. 1986;93:1124–31.CrossRefGoogle Scholar
  161. 161.
    Fielding J, Prior P, Waterhouse J, et al. Unpublished observations; 1969.Google Scholar
  162. 162.
    Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn’s Relapse Prevention Trial Study Group. Gastroenterology. 1994;106:287–96.CrossRefPubMedGoogle Scholar
  163. 163.
    Lask B, Jenkins J, Nabarro L, et al. Psychosocial sequelae of stoma surgery for inflammatory bowel disease in childhood. Gut. 1987;28:1257–60.CrossRefPubMedPubMedCentralGoogle Scholar
  164. 164.
    Burnham WR, Lennard-Jones JE, Brooke BN. Sexual problems among married ileostomists. Survey conducted by The Ileostomy Association of Great Britain and Ireland. Gut. 1977;18:673–7.CrossRefPubMedPubMedCentralGoogle Scholar
  165. 165.
    Moody GA, Mayberry JF. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion. 1993;54:256–60.CrossRefPubMedGoogle Scholar
  166. 166.
    Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn’s disease: a case control study by European collaborative group. Gut. 1986;27:821–5.CrossRefPubMedPubMedCentralGoogle Scholar
  167. 167.
    Moody G, Probert CS, Srivastava EM, et al. Sexual dysfunction amongst women with Crohn’s disease: a hidden problem. Digestion. 1992;52:179–83.CrossRefPubMedGoogle Scholar
  168. 168.
    Saha S, Zhao YQ, Shah S, et al. Menstrual cycle changes in women with inflammatory bowel disease: a study from the Ocean State Crohn’s and Colitis Area Registry. Inflamm Bowel Dis. 2014;20:534–40.CrossRefPubMedPubMedCentralGoogle Scholar
  169. 169.
    Weber AM, Ziegler C, Belinson J, et al. Gynecologic history of women with inflammatory bowel disease. Obstet Gynecol. 1995;86:843–7.CrossRefPubMedGoogle Scholar
  170. 170.
    Kane SV, Sable K, Hanauer S. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol. 1998;93:1867–72.CrossRefPubMedGoogle Scholar
  171. 171.
    Bernstein MT, Graff LA, Targownik L, et al. Gastrointestinal symptoms before and during menses in women with IBD. Aliment Pharmacol Ther. 2012;36:135–44.CrossRefPubMedGoogle Scholar
  172. 172.
    Care AC on AH. ACOG Committee Opinion No. 349, November 2006: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol. 2006;108:1323–8.CrossRefGoogle Scholar
  173. 173.
    Willman EA, Collins WP, Clayton S. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. BJOG. 1976;83:337–41.CrossRefGoogle Scholar
  174. 174.
    Weber AM, Belinson J. Inflammatory bowel disease—a complicating factor in gynecologic disorders? Medscape Womens Health. 1997;2:4.PubMedGoogle Scholar
  175. 175.
    Baird DD, Narendranathan M, Sandler RS. Increased risk of pre-term birth for women with inflammatory bowel disease. Gastroenterology. 1990;99:987–94.CrossRefPubMedGoogle Scholar
  176. 176.
    Hudson M, Flett G, Sinclair T, et al. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet. 1997;58:229–37.CrossRefPubMedGoogle Scholar
  177. 177.
    Larzilliere I, Beau P. [Chronic inflammatory bowel disease and pregnancy. Case control study]. Gastroenterol Clin Biol. 1998;22:1056–60.Google Scholar
  178. 178.
    Orholm M, Fonager K, Sorensen HT. Risk of ulcerative colitis and Crohn’s disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol. 1999;94:3236–8.CrossRefPubMedGoogle Scholar
  179. 179.
    Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991;324:84–8.CrossRefPubMedGoogle Scholar
  180. 180.
    Peeters M, Nevans H, Baert F, et al. Familial aggregation in Crohn’s disease. Increased age, adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996;111:597–603.CrossRefPubMedGoogle Scholar
  181. 181.
    Yang H, McElree C, Roth MP, et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993;34:517–24.CrossRefPubMedPubMedCentralGoogle Scholar
  182. 182.
    Bennett RA, Rubin PH, Present D. Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology. 1991;100:1638–43.CrossRefPubMedGoogle Scholar
  183. 183.
    Klement E, Cohen RV, Boxman J, et al. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342–52.CrossRefPubMedGoogle Scholar
  184. 184.
    Mahadevan U, Sandborn WJ, Li DK, et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007;133:1106–12. CrossRefPubMedGoogle Scholar
  185. 185.
    Nørgård B, Fonager K, Sørensen HT, et al. Birth outcomes of women with ulcerative colitis: a nationwide danish cohort study. Am J Gastroenterol. 2000;95:3165–70.CrossRefPubMedGoogle Scholar
  186. 186.
    Dominitz JA, Young JCC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol. 2002;97:641–8.CrossRefPubMedGoogle Scholar
  187. 187.
    Bush MC, Patel S, Lapinski RH, et al. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med. 2004;15:237–41.CrossRefPubMedGoogle Scholar
  188. 188.
    Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol. 1989;160:998–1001.CrossRefPubMedGoogle Scholar
  189. 189.
    Reddy SI, Wolf J. Management issues in women with inflammatory bowel disease. J Am Osteopat Assoc. 2001;101:S17–23.Google Scholar
  190. 190.
    Reddy D, Murphy SJ, Kane SV, et al. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol. 2008;103:1203–9.CrossRefPubMedGoogle Scholar
  191. 191.
    Gould SR, Brash AR, Conolly ME, et al. Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins Med. 1981;6:165–82.CrossRefPubMedGoogle Scholar
  192. 192.
    Lamah M, Scott HJ. Inflammatory bowel disease and pregnancy. Int J Color Dis. 2002;17:216–22.CrossRefGoogle Scholar
  193. 193.
    Menon R, Velez DR, Thorsen P, et al. Ethnic differences in key candidate genes for spontaneous preterm birth: TNF-alpha and its receptors. Hum Hered. 2006;62:107–18.CrossRefPubMedGoogle Scholar
  194. 194.
    Miller J. Inflammatory bowel disease in pregnancy: a review. J R Soc Med. 1986;79:221–5.CrossRefPubMedPubMedCentralGoogle Scholar
  195. 195.
    Nørgård B, Hundborg HH, Jacobsen BA, et al. Disease activity in pregnant women with crohn’s disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol. 2007;102:1947–54.CrossRefPubMedGoogle Scholar
  196. 196.
    Schofield PF, Turnbull RB, Hawk W. Crohn’s disease and pregnancy. BMJ. 1970;2:364.CrossRefPubMedGoogle Scholar
  197. 197.
    Eidelman AI. Breastfeeding and the use of human milk: an analysis of the American Academy of Pediatrics 2012 Breastfeeding Policy Statement. Breastfeed Med. 2012;7:323–4.CrossRefPubMedGoogle Scholar
  198. 198.
    Larsen LA, Ito S, Koren G. Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother. 2003;37:1299–306.CrossRefPubMedGoogle Scholar
  199. 199.
    Orholm M, Binder V, Sorensen T, et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol. 2000;35:1075–81.CrossRefPubMedGoogle Scholar
  200. 200.
    Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988;29:990–6.CrossRefPubMedPubMedCentralGoogle Scholar
  201. 201.
    Martimbeau PW, Welch JS, Weiland LH. Crohn’s disease and pregnancy. Am J Obstet Gynecol. 1975;122:746–9.CrossRefPubMedGoogle Scholar
  202. 202.
    Wilks S. Morbid appearances in the intestine of Miss Bankes. Lond Med Gaz. 1859;2:264.Google Scholar
  203. 203.
    Gossage AM, Price FW. Proc R Soc Med. 1909;2:151–6.Google Scholar
  204. 204.
    MacDougall I. Ulcerative colitis and pregnancy. Lancet. 1956;2:641–3.CrossRefGoogle Scholar
  205. 205.
    Holzbach R. Toxic megacolon in pregnancy. Am J Dig Dis. 1969;14:908–10.CrossRefPubMedGoogle Scholar
  206. 206.
    Flatmark AL, Nordöy A, Gjone E. Radical surgery lor ulcerative colitis during pregnancy. Scand J Gastroenterol. 1971;6:45–7.CrossRefPubMedGoogle Scholar
  207. 207.
    Webb MJ, Sedlack R. Ulcerative colitis in pregnancy. Med Clin North Am. 1974;58:823–7.CrossRefPubMedGoogle Scholar
  208. 208.
    Peskin GW, Davis A. Acute fulminating ulcerative colitis with colonic distension. Surg Gynecol Obstet. 1960;110:269–76.PubMedGoogle Scholar
  209. 209.
    Marshak RH, Korelitz BJ, Klein S, et al. Toxic dilatation of the colon in the course of ulcerative colitis. Gastroenterology. 1960;38:165–80.PubMedGoogle Scholar
  210. 210.
    Maddix B. Ulcerative colitis and pregnancy. Minn Med. 1962;45:1097–102.Google Scholar
  211. 211.
    Jalan KN, Sircus W, Card W, et al. An experience of ulcerative colitis. I. Toxic dilatation in 55 cases. Gastroenterology. 1969;57:68–82.PubMedGoogle Scholar
  212. 212.
    Ritchie JK. Ileostomy and excisional surgery for chronic inflammatory disease of the colon: a survey of one hospital region. Gut. 1971;12:528–40.CrossRefPubMedPubMedCentralGoogle Scholar
  213. 213.
    Cooksey G, Gunn A, Wotherspoon W. Surgery for acute ulcerative colitis and toxic megacolon during pregnancy. Br J Surg. 1985;72:547.CrossRefPubMedGoogle Scholar
  214. 214.
    Herrington A, Gala R, Beck DE, et al. Bowel obstruction in a pregnant patient with a restorative proctocolectomy and ileoanal J-pouch: a case report. Ochsner J. 2012;12:170–2.PubMedPubMedCentralGoogle Scholar
  215. 215.
    Walker M, Sylvain J, Stern H. Bowel obstruction in a pregnant patient with ileal pouch-anal anastomosis. Can J Surg. 1997;40:471–3.PubMedPubMedCentralGoogle Scholar
  216. 216.
    Edwards FC, Truelove S. The course and prognosis of ulcerative colitis. Gut. 1963;4:299–315.CrossRefPubMedPubMedCentralGoogle Scholar
  217. 217.
    Katz JA, Pore G. Inflammatory bowel disease and pregnancy. Inflamm Bowel Dis. 2001;7:146–57.CrossRefPubMedGoogle Scholar
  218. 218.
    Siddiqui AA, Mahboob A, Ansari M, et al. Effect of pregnancy on the disease activity in ulcerative colitis. J Postgrad Med Inst. 2011;25:314–7.Google Scholar
  219. 219.
    Vender RJ, Spiro HM. Inflammatory bowel disease and pregnancy. J Clin Gastroenterol. 1982;4:231–49.CrossRefPubMedGoogle Scholar
  220. 220.
    Jarnerot G. Fertility, sterility and pregnancy in chronic inflammatory bowel disease. Scand J Gastroenterol. 1982;17:1–4.CrossRefPubMedGoogle Scholar
  221. 221.
    De Dombal FT, Watts JM, Watkinson G, et al. Ulcerative colitis and pregnancy. Lancet. 1965;2:599–602.CrossRefPubMedGoogle Scholar
  222. 222.
    Mogadam M, Dobbins WO, Korelitz BI, et al. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology. 1981;80:72–6.PubMedGoogle Scholar
  223. 223.
    Donaldson RM Jr. Management of medical problems in pregnancy—inflammatory bowel disease. N Engl J Med. 1985;312:1616–9.CrossRefPubMedGoogle Scholar
  224. 224.
    Levy N, Roisman I, Teodor I. Ulcerative colitis in pregnancy in Israel. Dis Colon Rectum. 1981;24(5):351–4.CrossRefPubMedGoogle Scholar
  225. 225.
    Sykes L, MacIntyre DA, Yap X, et al. Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy•D,(12,14)prostaglandin J2. Mediators Inflamm. 2012;2012:416739.PubMedPubMedCentralGoogle Scholar
  226. 226.
    Spina V, Giovannini M, Fabiani C, et al. Postpartum complications in a patient with a previous proctocolectomy and ileo-pouch-anal anastomosis (IPAA) for ulcerative colitis. J Prenat Med. 2012;6:31–3.PubMedPubMedCentralGoogle Scholar
  227. 227.
    Mourelle M, Casellas F, Guarner F, et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology. 1995;109:1497–502.CrossRefPubMedGoogle Scholar
  228. 228.
    Guslandi M. Nitric oxide and inflammatory bowel diseases. Eur J Clin Invest. 1998;28:904–7.CrossRefPubMedGoogle Scholar
  229. 229.
    Dan U, Rabinovici J, Koller M, et al. Iatrogenic mechanical ileus due to over-distended uterus. Gynecol Obstet Invest. 1988;25:143–4.CrossRefPubMedGoogle Scholar
  230. 230.
    Quddus A, Martin-Perez B, Schoonyoung H, et al. Toxic megacolon during pregnancy in ulcerative colitis: a case report. Int J Surg Case Rep. 2015;11:83–6.CrossRefPubMedPubMedCentralGoogle Scholar
  231. 231.
    Chartrand-Lefebvre C, Heppel J, Potvin C, et al. Outcome of toxic megacolon during pregnancy. Can J Gastroenterol. 1990;4:230–4.CrossRefGoogle Scholar
  232. 232.
    Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1201–5.Google Scholar
  233. 233.
    Rouphael NG, O’Donnell JA, Bhatnagar J, et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol. 2008;198:e1–6.CrossRefGoogle Scholar
  234. 234.
    Pépin J, Valiquette L, Alary M, et al. Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466–72.CrossRefPubMedPubMedCentralGoogle Scholar
  235. 235.
    Gourevitch D, Hawkey P. Clostridium difficile infection and surgery. Br J Surg. 2009;96:3–4.CrossRefPubMedGoogle Scholar
  236. 236.
    Shi HY, Ng SC, Tsoi K, et al. The role of capsule endoscopy in assessing mucosal inflammation in ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2014;25:1–8.Google Scholar
  237. 237.
    Ooi BS, Remzi FH, Fazio VW. Turnbull-blowhole colostomy for toxic ulcerative colitis in pregnancy: report of two cases. Dis Colon Rectum. 2003;46:111–5.CrossRefPubMedGoogle Scholar
  238. 238.
    Greenfield C, Pounder RE, Craft IL, et al. Severe ulcerative colitis during successful pregnancy. Postgrad Med J. 1983;59:459–61.CrossRefPubMedPubMedCentralGoogle Scholar
  239. 239.
    Anderson JB, Turner GM, Williamson RC. Fulminant ulcerative colitis in late pregnancy and the puerperium. J R Soc Med. 1987;80:492–4.CrossRefPubMedPubMedCentralGoogle Scholar
  240. 240.
    Orabona R, Valcamonico A, Salemme M, et al. Fulminant ulcerative colitis in a healthy pregnant woman. World J Gastroenterol. 2015;21:6060–4.CrossRefPubMedPubMedCentralGoogle Scholar
  241. 241.
    Bohe MG, Ekelund GR, Genell S, et al. Surgery for fulminating colitis during pregnancy. Dis Colon Rectum. 1983;26:119–22.CrossRefPubMedGoogle Scholar
  242. 242.
    Becker I. Pregnancy and toxic dilatation of the colon. Am J Dig Dis. 1972;17:79–84.CrossRefPubMedGoogle Scholar
  243. 243.
    Heppell J, Farkouh E, Dube S, et al. Toxic megacolon, an analysis of 70 cases. Dis Colon Rectum. 1986;29:789–92.CrossRefPubMedGoogle Scholar
  244. 244.
    Fazio V. Toxic megacolon in ulcerative colitis and Crohn’s colitis. Clin Gastroenterol. 1980;9:389–407.PubMedGoogle Scholar
  245. 245.
    Haq AI, Sahai A, Hallwoth S, et al. Synchronous colectomy and caesarean section for fulminant ulcerative colitis: case report and review of the literature. Int J Colorectal Dis. 2006;21:465–9.CrossRefPubMedGoogle Scholar
  246. 246.
    Turnbull RB Jr, Hawk WA, Weakley F. Surgical treatment of toxic megacolon. Ileostomy and colostomy to prepare patients for colectomy. Am J Surg. 1971;122:325–31.CrossRefPubMedGoogle Scholar
  247. 247.
    Crile GC Jr, Thomas JC. The treatment of acute toxic ulcerative colitis by ileostomy and simultaneous colectomy. Gastroenterology. 1951;19:58–68.PubMedGoogle Scholar
  248. 248.
    Penna C, Daude F, Parc R, et al. Previous subtotal colectomy with ileostomy and sigmoidostomy improves the morbidity and early functional results after ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum. 1993;36:343–8.CrossRefPubMedGoogle Scholar
  249. 249.
    Toiyama Y, Araki T, Yoshiyama S, et al. Fulminant ulcerative colitis during pregnancy successfully treated by three-stage operation. J Gastroenterol. 2004;39:300–1.CrossRefPubMedGoogle Scholar
  250. 250.
    Hahnloser D, Pemberton JH, Wolff BG, et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum. 2004;47:1127–35.CrossRefPubMedGoogle Scholar
  251. 251.
    Kitayama T, Funayama Y, Fukushima K, et al. Anal function during pregnancy and postpartum after ileal pouch anal anastomosis for ulcerative colitis. Surg Today. 2005;35:211–5.CrossRefPubMedGoogle Scholar
  252. 252.
    Ravid A, Richard CS, Spencer LM, et al. Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2002;45(10):1283–8.CrossRefPubMedGoogle Scholar
  253. 253.
    Farouk R, Pemberton JH, Wolff B, et al. Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg. 2000;231:919–26.CrossRefPubMedPubMedCentralGoogle Scholar
  254. 254.
    Pezim M. Successful childbirth after restorative proctocolectomy with pelvic ileal reservoir. Br J Surg. 1984;71:292.CrossRefPubMedGoogle Scholar
  255. 255.
    Bradford K, Melmed GY, Fleshner P, et al. Significant variation in recommendation of care for women of reproductive age with ulcerative colitis postileal pouch-anal anastomosis. Dig Dis Sci. 2014;59:1115–20.CrossRefPubMedGoogle Scholar
  256. 256.
    Metcalf AM, Dozois RR, Kelly K. Sexual function in women after proctocolectomy. Ann Surg. 1986;204:624–7.CrossRefPubMedPubMedCentralGoogle Scholar
  257. 257.
    Lepistö A, Sarna S, Tiitinen A, et al. Female fertility and childbirth after ileal pouch–anal anastomosis for ulcerative colitis. Br J Surg. 2007;94:478–82.CrossRefPubMedGoogle Scholar
  258. 258.
    Silver RM, Landon MB, Rouse D, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107:1226–32.CrossRefGoogle Scholar
  259. 259.
    Barnes CS, Hayes H. Ulcerative colitis complicating pregnancy and the puerperium. Am J Obstet Gynecol. 1931;22:907–12.CrossRefGoogle Scholar
  260. 260.
    Granchow MI, Benjamin H. Inflammatory colorectal disease and pregnancy. Dis Colon Rectum. 1975;18:706–9.CrossRefGoogle Scholar
  261. 261.
    Banks BM, Korelitz BI, Zetzel L. The course of nonspecific ulcerative colitis: review of twenty years’ experience and late results. Gastroenterology. 1957;32:983–1012.PubMedGoogle Scholar
  262. 262.
    Schade RR, Van Thiel DH, Gavaler JS. Chronic idiopathic ulcerative colitis. Pregnancy and fetal outcome. Dig Dis Sci. 1984;29:614–9.CrossRefPubMedGoogle Scholar
  263. 263.
    Olsen KØ, Joelsson M, Laurberg S, Oresland T. Fertility after ileal pouch–anal anastomosis in women with ulcerative colitis. Br J Surg. 1999;86:493–5.CrossRefPubMedGoogle Scholar
  264. 264.
    Ørding Olsen K, Juul S, Berndtsson I, et al. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology. 2002;122:15–9.CrossRefPubMedGoogle Scholar
  265. 265.
    Waljee A, Waljee J, Morris AM, et al. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55:1575–80.CrossRefPubMedPubMedCentralGoogle Scholar
  266. 266.
    Johnson P, Richard C, Ravid A, et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2004;47:1119–26.CrossRefPubMedGoogle Scholar
  267. 267.
    Wikland M, Jansson I, Asztély M, et al. Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy. Int J Colorectal Dis. 1990;5:49–52.CrossRefPubMedGoogle Scholar
  268. 268.
    Olsen KØ, Juul S, Bülow S, et al. Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg. 2003;90:227–31.CrossRefPubMedGoogle Scholar
  269. 269.
    Indar AA, Efron JE, Young-Fadok T. Laparoscopic ileal pouch–anal anastomosis reduces abdominal and pelvic adhesions. Surg Endosc. 2009;23:174–7.CrossRefPubMedGoogle Scholar
  270. 270.
    Mortier P, Gambiez L, Karoui M, et al. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin Biol. 2006;30:594–7.CrossRefPubMedGoogle Scholar
  271. 271.
    Van Horn C, Barrett P. Pregnancy, delivery, and postpartum experiences of fifty-four women with ostomies. J Wound Ostomy Cont Nurs. 1997;24:151–62.CrossRefGoogle Scholar
  272. 272.
    Bartels SA, D’Hoore A, Cuesta M, et al. Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg. 2012;256:1045–8.CrossRefPubMedGoogle Scholar
  273. 273.
    Beyer-Berjot L, Maggiori L, Birnbaum D, et al. A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study. Ann Surg. 2013;258:275–82.CrossRefPubMedGoogle Scholar
  274. 274.
    Dubinsky M, Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflamm Bowel Dis. 2008;14:1736–50.CrossRefPubMedGoogle Scholar
  275. 275.
    Gorgun E, Remzi FH, Golberg J, et al. Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis: a study of 300 patients. Surgery. 2004;136:795–803.CrossRefPubMedGoogle Scholar
  276. 276.
    Oresland T, Palmblad S, Ellström M, et al. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Color Dis. 1994;9:77–81.CrossRefGoogle Scholar
  277. 277.
    Norgard B, Puho E, Pedersen L, et al. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol. 2003;98:2006–10.PubMedGoogle Scholar
  278. 278.
    Elbaz G, Fich A, Levy A, et al. Inflammatory bowel disease and preterm delivery. Int J Gynaecol Obstet. 2005;90:193–7.CrossRefPubMedGoogle Scholar
  279. 279.
    Georgy F. Fulminating ulcerative colitis in pregnancy. Obstet Gynecol. 1974;44:603–6.PubMedGoogle Scholar
  280. 280.
    Junghanns K. Pregnancy and ulcerative colitis. Langenbecks Arch Chir. 1982;356:285–8.Google Scholar
  281. 281.
    Boulton R, Hamilton M, Lewis A, et al. Fulminant Ulcerative colitis in pregnancy. Am J Gastroenterol. 1994;89:931–3.PubMedGoogle Scholar
  282. 282.
    Wilson IA, Dench J, Garrett W. Surgical management of ulcerative colitis in an ongoing pregnancy: report of a case and literature review. Int J Color Dis. 2014;29:271.CrossRefGoogle Scholar
  283. 283.
    Hashim E, Belliveau P. Toxic megacolon in pregnancy: a case report. J Obstet Gynaecol Can. 1998;20:74–7.Google Scholar
  284. 284.
    Soin B, Thyveetil MD, Desai A. Sub-total colectomy for perforated toxic megacolon in pregnancy. J Obstet Gynaecol. 1998;18:601.CrossRefPubMedGoogle Scholar
  285. 285.
    Uchino M, Ikeuchi H, Matsuoka H, et al. Surgery for severe ulcerative colitis during pregnancy: Report of two cases. Case Rep Gastroenterol. 2015;9:74–80.CrossRefPubMedPubMedCentralGoogle Scholar
  286. 286.
    Rajapakse R, Korelitz BI. Inflammatory bowel disease during pregnancy. Curr Treat Options Gastroenterol. 2001;4:245–51.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Goran Augustin
    • 1
    • 2
  1. 1.School of Medicine University of ZagrebZagrebCroatia
  2. 2.Department of SurgeryUniversity Hospital Centre ZagrebZagrebCroatia

Personalised recommendations